Pharmaceuticals Dry Syrup

Manufacturer of a wide range of products which include each 5ml contains: cefixime 50mg and each 5ml contains: amoxycillin 200 mg clavulanic acid 28..

Each 5ml Contains: Cefixime 50mg

Each 5ml Contains: Cefixime 50mg
  • Each 5ml Contains: Cefixime 50mg
Get Best Quote
Approx. Price: Rs 53 / PieceGet Latest Price

Product Details:

Minimum Order Quantity1000 Piece
Dosage FormSyrup
Packaging SizePlastic Bottle
Dose/Strength50 mg

To cater the variegated demands of our prestigious clients, we are the prominent supplier to offer a wide range of product to our clients. Our offered product is precisely designed and using the best grade basic material and modern technology. The provided product is highly appreciated by our clients owing to its optimum strength and durability. Furthermore, to avoid any flaws, the offered product is tested by our quality controllers on various quality parameters
Request
Callback


Additional Information:

  • Pay Mode Terms: T/T (Bank Transfer)
Yes! I am Interested

Each 5ml Contains: Amoxycillin 200 Mg Clavulanic Acid 28.

Each 5ml Contains: Amoxycillin 200 Mg  Clavulanic Acid  28.
  • Each 5ml Contains: Amoxycillin 200 Mg  Clavulanic Acid  28.
Get Best Quote
Approx. Price: Rs 53 / PieceGet Latest Price

Product Details:

Minimum Order Quantity1000 Piece
Dosage FormSyrup
Packaging Size20 ml
UsageClinical, Hospital

To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension, USP and other antibacterial drugs, amoxicillin and clavulanate potassium for oral suspension, USP should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Amoxicillin and clavulanate potassium for oral suspension, USP is indicated for the treatment of pediatric patients with recurrent or persistent acute otitis media due to S. pneumoniae (penicillin MICs ≤ 2 mcg/mL), H. influenzae (including beta-lactamase – producing strains), or M. catarrhalis (including beta-lactamase-­producing strains) characterized by the following risk factors:

Request
Callback


Additional Information:

  • Pay Mode Terms: T/T (Bank Transfer)
Yes! I am Interested
X

Explore more products



Reach Us
Swaran Singh (Director)
SCF-266, 1st Floor, Motor Market
Manimajra, Chandigarh -160101,India



Call Us

Share Us

F GT L


Send E-mailSend SMS